scispace - formally typeset
T

Takehito Yoshida

Researcher at Keio University

Publications -  6
Citations -  115

Takehito Yoshida is an academic researcher from Keio University. The author has contributed to research in topics: Total synthesis & Bafilomycin. The author has an hindex of 4, co-authored 6 publications receiving 115 citations.

Papers
More filters
Journal ArticleDOI

Total synthesis of bafilomycin A1

TL;DR: The highly stereoselective total synthesis of the macrolide antibiotic, bafilomycin A(1) (1), the first specific potent inhibitor of vacuolar H(+)-ATPase, has been achieved by a convergent route involving the synthesis and coupling of its 16-membered tetraenic lactone and beta-hydroxyl hemiacetal side-chain subunits.
Journal ArticleDOI

De novo highly stereocontrolled synthesis of 2,6-dideoxy sugars by use of 2,6-anhydro-2-thio sugars

TL;DR: In this article, the C-3 carbonyl groups of 2,6-dideoxy-3- O -methyl- l - ribo-hexopyranose ( l -cymarose) were synthesized by a highly stereoselective addition of a nucleophilic reagent.
Journal ArticleDOI

Application of efficient glycosylation of 2,6-anhydro-2-thio sugar to the total synthesis of erythromycin A

TL;DR: In this article, the total synthesis of erythromycin A ( I ) from (9S)-9-dihydroerythronolide A (2) was achieved efficiently by the highly stereoselective and powerful glycosylation of 2,6-anhydro-2-thio sugar 9 as a key step.
Journal ArticleDOI

De novo highly stereocontrolled synthesis of 2,6-dideoxy-C-3-branched carbohydrates by use of 2,6-anhydro-2-thio sugar : L-cladinose and its C-3 epimer

TL;DR: In this article, a highly stereoselective addition of methyl anion to the C-3 carbonyl groups of α-anomer 9 and β -anomer 10 having 2,6-anhydro-2-thio structures, were synthesized from the common intermediate 6 in stereocontrolled fashion.
Journal ArticleDOI

Total Synthesis of Bafilomycin A1.

TL;DR: In this article, a convergent route involving the synthesis and coupling of 16-membered tetraenic lactone and β-hydroxyl hemiacetal side-chain subunits was used to achieve the first specific potent inhibitor of vacuolar H+-ATPase.